Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Meningitis

• Amphotericin B for Non-HIV Cryptococcal Meningitis Patients
• Intensified Short Course Regimen for TBM in Adults
• Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
• Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial 3
• Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis
• Aciclovir Versus Placebo for HSV-2 Meningitis
• Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
• Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine
• Cyclophosphamide in the Treatment of Refractory Proliferative Arachnoiditis in CNS Tuberculosis
• The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia
• Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
• AmB Dose for Cryptococcal Meningitis
• Three Induction Treatments on Cryptococcal Meningitis
• Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial (EnACT)
• Adjunctive Linezolid for the Treatment of Tuberculous Meningitis
• Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia
• Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBM
• Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis
• Pharmacokinetic Study of Linezolid for TB Meningitis
• Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis
• Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018
• Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida Meningitis
• Open and Exploratory Trial to Investigate the Pharmacokinetic of Ceftobiprole Medocaril in Patients With CSF Device
• Treatment With Tamoxifen in Cryptococcal Meningitis
• Leukotriene A4 Hydrolase Stratified Trial of Adjunctive Corticosteroids for HIV-uninfected Adults With Tuberculous Meningitis
• Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults (The ACT HIV Trial)
• Hypovitaminosis D in Neurocritical Patients
• Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF)
• Ciprofloxacin for the Prevention of Meningococcal Meningitis
• Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis
• Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS
• The Relationships Between Gene Polymorphisms of LTA4H and Dexamethasone Treatment for Tuberculous Meningitis
• Pertussis and Meningitis C Concomitant Vaccination in Adolescents
• Vietnam Cryptococcal Retention in Care Study Version 1.0
• Aseptic Meningoencephalitis in Slovenia
• A Pilot Study of Adjunctive Aspirin for the Treatment of HIV Negative Adults With Tuberculous Meningitis
• High-dose Rifampicin for the Treatment of Tuberculous Meningitis: a Dose-finding Study
• Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis
• Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation
• Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis
• Pharmacological Study of High Doses of Ceftriaxone in Meningitidis
• Study Evaluating Efficiency and Tolerance of High-dose Fluconazole Associated With Flucytosine as Induction Therapy for Cryptococcal Meningitis Associated With HIV in Sub-saharan Africa
• WEUSKOP6166: Lamotrigine and Aseptic Meningitis
• Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term
• Lumbar Punctures in Neonates: Improving Success Rates and Minimizing Pain
• Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis
• Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
• Operational Research for Cryptococcal Antigen Screening
• Daptomycin in Pediatric Patients With Bacterial Meningitis
• Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old.
• Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
• Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis
• A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of Age
• Infant Severe Sepsis and Bacterial Meningitis in Malawi
• Intensified Treatment Regimens for TB Meningitis: PK, PD and Tolerability Study
• Cryptococcal Optimal ART Timing Trial
• Cerebrospinal Fluid Pharmacokinetics of Daptomycin
• Depocyt® With Sorafenib in Neoplastic Meningitis
• Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults
• A Pilot Study of Bevacizumab for Neoplastic Meningitis
• High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals
• Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis
• Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa
• Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration
• Phase 1 Intrathecal Topotecan for Neoplastic Meningitis
• Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
• A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis
• DepoCyt for Active Lymphomatous or Leukemic Meningitis
• DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis
• RTA 744 Injection in Patients With Leptomeningeal Disease
• Impact of Daily Zinc Supplementation to Infants Born With Low Birth Weight on Death and Severe Disease
• Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous Meningitis
• Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections
• High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations
• Amikacin Penetration Into the Cerebrospinal Fluid
• Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS
• A Phase I Study of Intrathecal Rituximab in Patients With Lymphomatous Meningitis
• Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis
• Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
• Intrathecal Gemcitabine to Treat Neoplastic Meningitis, IT Gemcitabine
• DepoCyt Therapy in Patients With Neoplastic Meningitis From Lymphoma or a Solid Tumor
• Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
• Melphalan in Patients With Neoplastic Meningitis
• The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis
• A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B
• A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
• A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
• A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.
• An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
• Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
• Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
• Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
• A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
• Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
• Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
• Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis
• Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
• Dexamethasone in Cryptococcal Meningitis
• Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
• SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
• A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis